For informational purposes only. Data on this page is aggregated from public sources (SEC EDGAR, FINRA, and similar databases) and does not constitute financial advice, a recommendation to buy or sell any security, or professional investment guidance. Guerilla Finance LLC is not a registered investment advisor. Always conduct your own research and consult a licensed financial professional before making investment decisions. Full disclaimer →
Farallon Capital
Thomas Steyer
hedge fundevent driven
Portfolio Value
$17.5B
Positions
172
Quarter
2026-03-31
New Positions
0
Exits
0
Portfolio Value History — 8 Quarters
| Ticker | Value | Shares | % of Portfolio |
|---|---|---|---|
STATE STR Put | $1.5B | 2.3M | 8.5% |
| $1.3B | 13.6M | 7.5% | |
| $878.6M | 4.2M | 5.0% | |
| $868.0M | 2.3M | 4.9% | |
AON PLC | $811.0M | 2.5M | 4.6% |
| $695.5M | 9.4M | 4.0% | |
INVESCO EXPut | $690.9M | 3.6M | 3.9% |
| $669.2M | 6.3M | 3.8% | |
| $641.4M | 3.2M | 3.7% | |
| $562.3M | 13.1M | 3.2% | |
| $550.8M | 1.8M | 3.1% | |
| $492.9M | 1.8M | 2.8% | |
| $481.0M | 1.2M | 2.7% | |
| $468.8M | 7.5M | 2.7% | |
| $433.3M | 881.5K | 2.5% | |
| $432.1M | 4.7M | 2.5% | |
| $423.5M | 5.6M | 2.4% | |
| $402.2M | 1.6M | 2.3% | |
| $371.8M | 4.0M | 2.1% | |
| $326.7M | 8.7M | 1.9% | |
| $302.8M | 8.3M | 1.7% | |
| $285.8M | 996.2K | 1.6% | |
ROIVANT SC | $268.0M | 9.7M | 1.5% |
| $254.1M | 840.7K | 1.4% | |
| $248.7M | 6.1M | 1.4% | |
| $241.5M | 10.1M | 1.4% | |
| $231.5M | 2.4M | 1.3% | |
| $217.4M | 435.1K | 1.2% | |
| $202.8M | 234.3K | 1.2% | |
| $192.3M | 5.7M | 1.1% | |
| $191.0M | 4.8M | 1.1% | |
| $190.3M | 9.1M | 1.1% | |
GRAIL INC | $168.2M | 3.3M | 1.0% |
TYRA BIOSC | $137.1M | 3.6M | 0.8% |
| $85.3M | 452.2K | 0.5% | |
| $77.8M | 368.0K | 0.4% | |
| $73.3M | 1.3M | 0.4% | |
DIANTHUS T | $70.2M | 836.0K | 0.4% |
BRIGHTSPRI | $68.9M | 1.6M | 0.4% |
| $67.8M | 1.4M | 0.4% | |
| $49.4M | 443.8K | 0.3% | |
CG ONCOLOG | $45.6M | 674.0K | 0.3% |
ASTRAZENEC | $44.7M | 226.5K | 0.3% |
VNET GROUP | $44.5M | 45.0M | 0.3% |
| $43.4M | 361.0K | 0.2% | |
| $40.6M | 1.7M | 0.2% | |
| $39.5M | 200.0K | 0.2% | |
| $38.4M | 1.5M | 0.2% | |
| $36.3M | 2.9M | 0.2% | |
| $36.2M | 148.0K | 0.2% | |
BETA BIONI | $36.2M | 3.6M | 0.2% |
ASSEMBLY B | $34.1M | 1.2M | 0.2% |
| $33.8M | 578.2K | 0.2% | |
STRATEGY I | $32.9M | 39.5M | 0.2% |
| $32.6M | 291.2K | 0.2% | |
| $28.7M | 782.0K | 0.2% | |
BITWISE 10 | $26.9M | 603.0K | 0.2% |
PERCEPTIVE | $24.7M | 2.3M | 0.1% |
ROYALTY PH | $23.6M | 493.0K | 0.1% |
MINERVA NE | $14.2M | 2.4M | 0.1% |
| $13.9M | 234.0K | 0.1% | |
AVALO THER | $13.7M | 916.0K | 0.1% |
CG ONCOLOGCall | $13.5M | 200.0K | 0.1% |
| $11.8M | 292.0K | 0.1% | |
MAZE THERA | $11.1M | 373.0K | 0.1% |
| $10.7M | 354.0K | 0.1% | |
| $5.5M | 56.5K | 0.0% | |
| $5.5M | 17.0K | 0.0% | |
| $5.3M | 45.5K | 0.0% | |
| $5.3M | 47.0K | 0.0% | |
| $5.2M | 623.3K | 0.0% | |
| $5.2M | 36.0K | 0.0% | |
| $5.2M | 73.0K | 0.0% | |
| $5.1M | 51.0K | 0.0% | |
FLEXTRONIC | $5.1M | 78.0K | 0.0% |
| $5.1M | 12.0K | 0.0% | |
| $5.1M | 15.0K | 0.0% | |
PIPER SAND | $5.1M | 66.0K | 0.0% |
| $5.0M | 46.0K | 0.0% | |
| $5.0M | 53.8K | 0.0% | |
| $5.0M | 275.0K | 0.0% | |
| $5.0M | 93.0K | 0.0% | |
| $4.9M | 108.0K | 0.0% | |
INTER & CO | $4.9M | 614.5K | 0.0% |
| $4.8M | 9.0K | 0.0% | |
| $4.8M | 86.0K | 0.0% | |
| $4.8M | 19.0K | 0.0% | |
| $4.7M | 104.0K | 0.0% | |
ATRIUM THE | $4.7M | 349.4K | 0.0% |
GLOBALFOUN | $4.7M | 105.0K | 0.0% |
| $4.7M | 35.0K | 0.0% | |
OPUS GENET | $4.5M | 1.0M | 0.0% |
| $4.5M | 265.0K | 0.0% | |
PRIME MEDI | $4.3M | 1.2M | 0.0% |
| $4.3M | 41.0K | 0.0% | |
SUMMIT MID | $1.8M | 58.2K | 0.0% |
| $1.7M | 3.3K | 0.0% | |
CAPRICOR T | $1.2M | 41.0K | 0.0% |
| $991K | 15.8K | 0.0% | |
ALEANNA IN | $802K | 990.0K | 0.0% |
| $739K | 8.0K | 0.0% | |
ALKERMES P | $735K | 20.8K | 0.0% |
ALVOTECH | $685K | 199.7K | 0.0% |
| $676K | 4.0K | 0.0% | |
| $654K | 17.0K | 0.0% | |
ALEANNA IN | $650K | 78.4K | 0.0% |
| $613K | 26.0K | 0.0% | |
| $457K | 4.0K | 0.0% | |
LIVANOVA P | $381K | 6.0K | 0.0% |
| $369K | 7.0K | 0.0% | |
| $360K | 4.8K | 0.0% | |
| $357K | 12.0K | 0.0% | |
| $345K | 4.0K | 0.0% | |
| $344K | 7.0K | 0.0% | |
| $327K | 1.1K | 0.0% | |
| $321K | 5.0K | 0.0% | |
| $314K | 1.0K | 0.0% | |
| $307K | 3.0K | 0.0% | |
| $306K | 18.0K | 0.0% | |
| $293K | 9.0K | 0.0% | |
| $291K | 18.0K | 0.0% | |
| $290K | 3.0K | 0.0% | |
NEKTAR THE | $288K | 4.0K | 0.0% |
| $280K | 2.6K | 0.0% | |
| $277K | 3.0K | 0.0% | |
| $269K | 14.0K | 0.0% | |
| $258K | 1.0K | 0.0% | |
| $243K | 23.0K | 0.0% | |
ALUMIS INC | $242K | 11.0K | 0.0% |
| $241K | 6.0K | 0.0% | |
| $234K | 2.8K | 0.0% | |
| $234K | 10.0K | 0.0% | |
| $231K | 16.0K | 0.0% | |
UNIQURE NV | $229K | 14.0K | 0.0% |
| $228K | 24.0K | 0.0% | |
| $225K | 7.0K | 0.0% | |
| $225K | 28.0K | 0.0% | |
ABIVAX SA | $223K | 2.0K | 0.0% |
| $214K | 3.0K | 0.0% | |
REVOLUTION | $209K | 120.1K | 0.0% |
| $208K | 10.0K | 0.0% | |
BELITE BIO | $207K | 1.3K | 0.0% |
| $207K | 3.0K | 0.0% | |
| $207K | 4.0K | 0.0% | |
| $204K | 12.0K | 0.0% | |
UROGEN PHA | $198K | 11.0K | 0.0% |
| $197K | 22.0K | 0.0% | |
| $194K | 50.0K | 0.0% | |
| $193K | 17.0K | 0.0% | |
| $181K | 10.0K | 0.0% | |
| $179K | 22.0K | 0.0% | |
| $178K | 135.0K | 0.0% | |
SELLAS LIF | $169K | 40.0K | 0.0% |
| $153K | 11.0K | 0.0% | |
| $152K | 18.0K | 0.0% | |
| $141K | 19.0K | 0.0% | |
| $138K | 23.0K | 0.0% | |
| $126K | 11.0K | 0.0% | |
| $124K | 29.0K | 0.0% | |
| $91K | 26.0K | 0.0% | |
SOLID POWE | $88K | 405.3K | 0.0% |
| $85K | 27.6K | 0.0% | |
| $74K | 28.0K | 0.0% | |
TVARDI THE | $68K | 21.4K | 0.0% |
| $64K | 43.0K | 0.0% | |
BLUE GOLD | $60K | 300.0K | 0.0% |
RANI THERA | $57K | 78.0K | 0.0% |
| $46K | 13.0K | 0.0% | |
| $32K | 14.0K | 0.0% | |
CANOPY GRO | $28K | 30.0K | 0.0% |
NVNI GROUP | $18K | 375.0K | 0.0% |
| $13K | 19.0K | 0.0% |
Filing History
| Quarter | Filed | Portfolio Value | Positions | SEC Filing |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $17.5B | 172 | View on EDGAR |
| 2025-12-31 | 2026-05-15 | $883.7M | 2 | View on EDGAR |
| 2025-12-31 | 2026-02-17 | $883.7M | 2 | View on EDGAR |
| 2025-09-30 | 2026-02-17 | $24.4B | 144 | View on EDGAR |
| 2025-09-30 | 2025-11-14 | $24.4B | 144 | View on EDGAR |
| 2025-06-30 | 2026-02-17 | $23.2B | 141 | View on EDGAR |
| 2025-06-30 | 2025-11-14 | $23.2B | 141 | View on EDGAR |
| 2025-06-30 | 2025-08-14 | $23.2B | 141 | View on EDGAR |